Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-12, with 63 holding rows worth $346,287,000.

Accession
0001387131-16-006501
Filed
2016-08-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 63 entries on the cover page, a total value of $346,287,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $346,287,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS350,000$40,243,000thousands by filing dateput
SPDR SER TR78464A870S&P BIOTECH400,000$21,632,000thousands by filing dateput
SPY78462F103SHS100,000$20,948,000thousands by filing dateput
GW PHARMACEUTICALS PLC36197T103ADS130,000$11,904,000thousands by filing dateput
OPHTHOTECH CORP683745103COM215,000$10,971,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM90,000$10,508,000thousands by filing date
NUVASIVE INC670704105COM150,000$8,958,000thousands by filing date
Medtronic PlcG5960L103COM100,000$8,677,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM110,000$8,558,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock85,000$8,477,000thousands by filing date
CONMED CORP COM207410101Stock175,000$8,353,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM325,000$8,289,000thousands by filing date
Boston Scientific Corporation101137107COM350,000$8,180,000thousands by filing datecall
Boston Scientific Corporation101137107COM325,000$7,595,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM575,000$7,383,000thousands by filing date
BLUEBIRD BIO INC09609G100COM170,000$7,359,000thousands by filing date
BIOGEN INC COM09062X103Stock30,000$7,255,000thousands by filing date
SPECTRANETICS CORP84760C107COM375,000$7,016,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM500,000$6,860,000thousands by filing dateput
CLOVIS ONCOLOGY INC189464100COM450,000$6,174,000thousands by filing date
NEVRO CORP64157F103COM80,000$5,901,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM300,000$5,721,000thousands by filing dateput
NEUROCRINE BIOSCIENCES INC64125C109COM125,000$5,681,000thousands by filing date
Lion Biotechnologies53619R102COM700,000$5,670,000thousands by filing date
K2M GROUP HLDGS INC48273J107COM350,000$5,432,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM200,000$5,179,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM35,000$4,994,000thousands by filing datecall
ENDOLOGIX INC29266S106COM400,000$4,984,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,700,000$4,828,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK120,000$4,658,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM150,000$4,520,000thousands by filing datecall
WRIGHT MED GROUP N VN96617118ORD SHS250,000$4,343,000thousands by filing date
TESARO INC881569107COM50,000$4,203,000thousands by filing date
TESARO INC881569107COM50,000$4,203,000thousands by filing datecall
HORIZON PHARMA PLCG4617B105SHS250,000$4,118,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock120,000$4,048,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM200,000$3,814,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON350,000$3,759,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS200,000$3,294,000thousands by filing datecall
RAPTOR PHARMACEUTICAL CORP75382F106COM600,000$3,222,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM250,000$3,150,000thousands by filing date
CELGENE CORP151020104COM25,000$2,466,000thousands by filing date
IMMUNOMEDICS INC452907108COM1,000,000$2,320,000thousands by filing date
ENTELLUS MED INC29363K105COM120,000$2,192,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM100,000$1,907,000thousands by filing datecall
INTERCEPT PHARMACEUTICALS IN45845P108COM12,700$1,812,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK800,000$1,784,000thousands by filing date
VERACYTE INC COM92337F107Stock341,708$1,719,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM150,000$1,355,000thousands by filing date
Alcobra LtdM2239P109SHS300,000$1,347,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR100,000$1,327,000thousands by filing date
Gilead Sciences,Inc.375558103COM15,000$1,251,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM150,000$1,131,000thousands by filing date
CORBUS PHARMACEUTICALS HLDGS21833P103COM300,000$897,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW20,000$735,000thousands by filing date
MEDIVATION INC58501N101COM10,500$633,000thousands by filing date
AKARI THERAPEUTICS PLC00972G108ADR46,622$629,000thousands by filing date
IMMUNOMEDICS INC452907108COM200,000$464,000thousands by filing datecall
HERON THERAPEUTICS INC427746102COM25,000$451,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM75,000$410,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM50,000$243,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW22,000$84,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM35,801$68,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-16-006501this filing2016-08-12acceptance time not in the bulk data set